Deutsche Bank upgraded ResMed (NYSE: RMD) from Hold to Buy with a price target of $54.00 (from $46.00). Analyst David ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE